Literature DB >> 14734055

Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways.

S-J Lin1, S-K Shyue, P-L Liu, Y-H Chen, H-H Ku, J-W Chen, K-B Tam, Y-L Chen.   

Abstract

In a variety of vascular disorders, endothelial cells (ECs) are exposed to high levels of reactive oxygen species (ROS) generated intercellularly. Recently, several anti-oxidants, including catalase, have been suggested to be cytoprotective against the development of atherosclerosis. The object of this study was to investigate whether adenovirus-mediated gene transfer of catalase in ECs can attenuate ROS production and cell apoptosis under oxidized low density lipoprotein (oxLDL) stimulation. Adenovirus-mediated gene transfer of human catalase gene (Ad-Cat) resulted in a high level of catalase overexpression in human arterial EC (HAEC), which manifested a time-dependent increase in cell viability under the exposure of oxLDL and decreased oxLDL-induced apoptosis. Phosphorylation studies of ERK1/2, JNK, and p38, three subgroups of mitogen activator protein kinase demonstrated that catalase overexpression suppressed JNK phosphorylation and increased ERK1/2 phosphorylation. NF-kappaB and AP-1 were induced after the exposure of HAECs to oxLDL. While catalase overexpression was found to inactivate AP-1, it had no effect on NF-kappaB activity. These results provide the evidence that overexpression of catalase in ECs attenuates ROS production and cell apoptosis under oxLDL stimulation. The protective effect is mediated through the downregulation of JNK and the upregulation of ERK1/2 phosphorylation as well as AP-1 inactivation. This observation supports the feasibility of catalase gene transfer to human endothelium to protect against oxidant injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734055     DOI: 10.1016/j.yjmcc.2003.10.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  18 in total

Review 1.  Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury.

Authors:  Christopher A Papaharalambus; Kathy K Griendling
Journal:  Trends Cardiovasc Med       Date:  2007-02       Impact factor: 6.677

2.  Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway.

Authors:  Gudrun Ulrich-Merzenich; Heike Zeitler; Darius Panek; Dirk Bokemeyer; Hans Vetter
Journal:  Eur J Nutr       Date:  2007-03       Impact factor: 5.614

3.  Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells.

Authors:  A Abderrahmani; G Niederhauser; D Favre; S Abdelli; M Ferdaoussi; J Y Yang; R Regazzi; C Widmann; G Waeber
Journal:  Diabetologia       Date:  2007-04-17       Impact factor: 10.122

4.  Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II.

Authors:  Seung-il Choi; Tae-im Kim; Kyu Seo Kim; Bong-Yoon Kim; So-yeon Ahn; Hyun-ju Cho; Hyung Keun Lee; Hyun-Soo Cho; Eung Kweon Kim
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

5.  Extracellular superoxide dismutase is a growth regulatory mediator of tissue injury recovery.

Authors:  Juha P Laurila; Maria D Castellone; Antonio Curcio; Lilja E Laatikainen; Merja Haaparanta-Solin; Tove J Gronroos; Paivi Marjamaki; Satu Martikainen; Massimo Santoro; Mikko O Laukkanen
Journal:  Mol Ther       Date:  2008-12-23       Impact factor: 11.454

6.  PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress.

Authors:  Yong Wu; Hillary Zhou; Ke Wu; Sangkyu Lee; Ruijin Li; Xuan Liu
Journal:  Antioxid Redox Signal       Date:  2013-11-13       Impact factor: 8.401

7.  Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress.

Authors:  Alexander V Maksimenko; Alexander V Vavaev
Journal:  Heart Int       Date:  2012-02-03

8.  Cardiological biopharmaceuticals in the conception of drug targeting delivery: practical results and research perspectives.

Authors:  A V Maksimenko
Journal:  Acta Naturae       Date:  2012-07       Impact factor: 1.845

9.  The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease.

Authors:  Paul C Evans
Journal:  EPMA J       Date:  2011-02-12       Impact factor: 6.543

10.  6-Shogaol Protects against Oxidized LDL-Induced Endothelial Injruries by Inhibiting Oxidized LDL-Evoked LOX-1 Signaling.

Authors:  Yun Kai Wang; Ya Jun Hong; Yong Hua Yao; Xiao Min Huang; Xue Bo Liu; Chun Yu Zhang; Lei Zhang; Xiaoliang Leon Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.